Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Liesenfeld

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Ophthalmology|August 12, 1999
Use of the polymerase chain reaction for diagnosis of ocular toxoplasmosisJ G Montoya, S Parmley, O Liesenfeld, et al.
International Journal of Pharmaceutics|June 9, 2001
Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophagesN Schöler, C Olbrich, K Tabatt, et al.
Annals of Tropical Medicine and Parasitology|September 25, 2010
Congenital infections with Trypanosoma cruzi or Toxoplasma gondii are associated with decreased serum concentrations of interferon-γ and interleukin-18 but increased concentrations of interleukin-10J Patino Mayer, M Biancardi, J Altcheh, et al.
The Journal of Parasitology|October 19, 2010
Seroepidemiology of infection with Toxoplasma gondii in workers occupationally exposed to water, sewage, and soil in Durango, MexicoC Alvarado-Esquivel, O Liesenfeld, J A Márquez-Conde, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosisN Schöler, K Krause, O Kayser, et al.
European Journal of Microbiology & Immunology|November 23, 2013
Tim-3 is differently expressed in genetically susceptible C57BL/6 and resistant BALB/c mice during oral infection with Toxoplasma gondiiL C Berrocal Almanza, M Muñoz, A A Kühl, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1997
The number and proportion of Vgamma9 Vdelta2 T cells rise significantly in the peripheral blood of patients after the onset of acute Coxiella burnetii infectionT Schneider, H U Jahn, O Liesenfeld, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1996
IL-4 is protective against development of toxoplasmic encephalitisY Suzuki, Q Yang, S Yang, et al.
European Journal of Microbiology & Immunology|April 2, 2014
Treatment with interleukin-18 binding protein ameliorates Toxoplasma gondii-induced small intestinal pathology that is induced by bone marrow cell-derived interleukin-18D Struck, I Frank, S Enders, et al.
The Journal of Parasitology|February 26, 2011
Seroepidemiology of Toxoplasma gondii infection in general population in a northern Mexican cityC Alvarado-Esquivel, S Estrada-Martínez, H Pizarro-Villalobos, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Ophthalmology|August 12, 1999
Use of the polymerase chain reaction for diagnosis of ocular toxoplasmosisJ G Montoya, S Parmley, O Liesenfeld, et al.
International Journal of Pharmaceutics|June 9, 2001
Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophagesN Schöler, C Olbrich, K Tabatt, et al.
Annals of Tropical Medicine and Parasitology|September 25, 2010
Congenital infections with Trypanosoma cruzi or Toxoplasma gondii are associated with decreased serum concentrations of interferon-γ and interleukin-18 but increased concentrations of interleukin-10J Patino Mayer, M Biancardi, J Altcheh, et al.
The Journal of Parasitology|October 19, 2010
Seroepidemiology of infection with Toxoplasma gondii in workers occupationally exposed to water, sewage, and soil in Durango, MexicoC Alvarado-Esquivel, O Liesenfeld, J A Márquez-Conde, et al.
Antimicrobial Agents and Chemotherapy|May 17, 2001
Atovaquone nanosuspensions show excellent therapeutic effect in a new murine model of reactivated toxoplasmosisN Schöler, K Krause, O Kayser, et al.
European Journal of Microbiology & Immunology|November 23, 2013
Tim-3 is differently expressed in genetically susceptible C57BL/6 and resistant BALB/c mice during oral infection with Toxoplasma gondiiL C Berrocal Almanza, M Muñoz, A A Kühl, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1997
The number and proportion of Vgamma9 Vdelta2 T cells rise significantly in the peripheral blood of patients after the onset of acute Coxiella burnetii infectionT Schneider, H U Jahn, O Liesenfeld, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1996
IL-4 is protective against development of toxoplasmic encephalitisY Suzuki, Q Yang, S Yang, et al.
European Journal of Microbiology & Immunology|April 2, 2014
Treatment with interleukin-18 binding protein ameliorates Toxoplasma gondii-induced small intestinal pathology that is induced by bone marrow cell-derived interleukin-18D Struck, I Frank, S Enders, et al.
The Journal of Parasitology|February 26, 2011
Seroepidemiology of Toxoplasma gondii infection in general population in a northern Mexican cityC Alvarado-Esquivel, S Estrada-Martínez, H Pizarro-Villalobos, et al.
Pageof 7